217 related articles for article (PubMed ID: 26451311)
41. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
Kuehm LM; Wolf K; Zahour J; DiPaolo RJ; Teague RM
Cancer Immunol Immunother; 2019 Jul; 68(7):1095-1106. PubMed ID: 31104075
[TBL] [Abstract][Full Text] [Related]
42. Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors.
Pappas J; Jung WJ; Barda AK; Lin WL; Fincke JE; Purev E; Radu M; Gaughan J; Helm CW; Hernandez E; Freedman RS; Platsoucas CD
Cell Immunol; 2005 Apr; 234(2):81-101. PubMed ID: 16038891
[TBL] [Abstract][Full Text] [Related]
43. Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity.
Peng P; Yan Y; Keng S
Oncol Rep; 2011 Mar; 25(3):749-62. PubMed ID: 21181093
[TBL] [Abstract][Full Text] [Related]
44. Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL lines.
Fisk B; Flytzanis CN; Pollack MS; Wharton JT; Ioannides CG
Scand J Immunol; 1994 Dec; 40(6):591-600. PubMed ID: 7848491
[TBL] [Abstract][Full Text] [Related]
45. Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer.
Auer K; Bachmayr-Heyda A; Sukhbaatar N; Aust S; Schmetterer KG; Meier SM; Gerner C; Grimm C; Horvat R; Pils D
Oncotarget; 2016 Sep; 7(38):61336-61354. PubMed ID: 27665539
[TBL] [Abstract][Full Text] [Related]
46. Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.
Perrin G; Schnuriger V; Quiquerez AL; Saas P; Pannetier C; de Tribolet N; Tiercy JM; Aubry JP; Dietrich PY; Walker PR
Int Immunol; 1999 Aug; 11(8):1337-50. PubMed ID: 10421791
[TBL] [Abstract][Full Text] [Related]
47. Circulating CD8
Lin KR; Pang DM; Jin YB; Hu Q; Pan YM; Cui JH; Chen XP; Lin YX; Mao XF; Duan HB; Luo W
Cancer Immunol Immunother; 2018 Nov; 67(11):1743-1752. PubMed ID: 30167861
[TBL] [Abstract][Full Text] [Related]
48. Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging.
Kallemeijn MJ; Kavelaars FG; van der Klift MY; Wolvers-Tettero ILM; Valk PJM; van Dongen JJM; Langerak AW
Front Immunol; 2018; 9():448. PubMed ID: 29559980
[TBL] [Abstract][Full Text] [Related]
49. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
50. T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.
Beausang JF; Wheeler AJ; Chan NH; Hanft VR; Dirbas FM; Jeffrey SS; Quake SR
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10409-E10417. PubMed ID: 29138313
[TBL] [Abstract][Full Text] [Related]
51. Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.
Aris M; Bravo AI; Pampena MB; Blanco PA; Carri I; Koile D; Yankilevich P; Levy EM; Barrio MM; Mordoh J
Front Immunol; 2018; 9():955. PubMed ID: 29774030
[TBL] [Abstract][Full Text] [Related]
52. Characterization of the T-cell receptor repertoire by deep T cell receptor sequencing in tissues from patients with prostate cancer.
Liu S; Pan W; Cheng Z; Sun G; Zhu P; Chan F; Hu Y; Zhang X; Dai Y
Oncol Lett; 2018 Feb; 15(2):1744-1752. PubMed ID: 29399194
[TBL] [Abstract][Full Text] [Related]
53. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
Strauss G; Gückel B; Wallwiener D; Moldenhauer G
Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
[TBL] [Abstract][Full Text] [Related]
54. Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapy.
Zhang C; Palashati H; Tan Q; Ku W; Miao Y; Xiong H; Lu Z
Carcinogenesis; 2018 Dec; 39(11):1389-1398. PubMed ID: 30202955
[TBL] [Abstract][Full Text] [Related]
55. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
56. Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer.
Zheng X; Wang X; Cheng X; Liu Z; Yin Y; Li X; Huang Z; Wang Z; Guo W; Ginhoux F; Li Z; Zhang Z; Wang X
Nat Cancer; 2023 Aug; 4(8):1138-1156. PubMed ID: 37488416
[TBL] [Abstract][Full Text] [Related]
57. Select sequencing of clonally expanded CD8
Huang H; Sikora MJ; Islam S; Chowdhury RR; Chien YH; Scriba TJ; Davis MM; Steinmetz LM
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8995-9001. PubMed ID: 30992377
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer.
Tamura K; Hazama S; Yamaguchi R; Imoto S; Takenouchi H; Inoue Y; Kanekiyo S; Shindo Y; Miyano S; Nakamura Y; Kiyotani K
Oncol Lett; 2016 Jun; 11(6):3643-3649. PubMed ID: 27284367
[TBL] [Abstract][Full Text] [Related]
59. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.
Nishimura MI; Kawakami Y; Charmley P; O'Neil B; Shilyansky J; Yannelli JR; Rosenberg SA; Hood L
J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):85-94. PubMed ID: 7804531
[TBL] [Abstract][Full Text] [Related]
60. Pathologic T-cell response in ischaemic failing hearts elucidated by T-cell receptor sequencing and phenotypic characterization.
Tang TT; Zhu YC; Dong NG; Zhang S; Cai J; Zhang LX; Han Y; Xia N; Nie SF; Zhang M; Lv BJ; Jiao J; Yang XP; Hu Y; Liao YH; Cheng X
Eur Heart J; 2019 Dec; 40(48):3924-3933. PubMed ID: 31365073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
